Clinical Trials Logo

Clinical Trial Summary

This research is based on spleen trapped by dampness and turbid which is the pathogenesis of gouty arthritis.It uses effective prescription of Endocrinology of Dongzhimen Hospital.In this study, the investigators use multi-center randomized parallel controlled clinical trials.The treatment groups are afforded oral traditional Chinese medicine decoction-tonifying spleen and descending the turbid decoction as well as soaking and wet wrapping.The control groups are afforded diclofenac sodium enteric-coated tablets as a positive control drug.The outcome is evaluated by condition of symptoms remission,pain relief time, recurrence rate and laboratory index to determine the efficacy of internal and external treatment.And the research will provide optimized diagnosis and treatment program. The investigators hope this research will also get tonifying spleen and descending the turbid internal and external treatment for gouty arthritis effective clinical treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02545777
Study type Interventional
Source Beijing University of Chinese Medicine
Contact Wang Shi Dong, Doctor
Phone 13910965659
Email wsd3122@sina.cn
Status Recruiting
Phase Phase 2
Start date May 2014

See also
  Status Clinical Trial Phase
Withdrawn NCT01593527 - Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease Phase 3
Completed NCT01356602 - Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients Phase 3
Completed NCT00170781 - Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout Phase 4
Not yet recruiting NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare Phase 1
Completed NCT03002974 - A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis Phase 2
Completed NCT01431638 - Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients Phase 3